1. Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care. (21st March 2018) Authors: Behrens, Stephanie; Rattinger, Gail B.; Schwartz, Sarah; Matyi, Joshua; Sanders, Chelsea; DeBerard, M. Scott; Lyketsos, Constantine G.; Tschanz, JoAnn T. Journal: International psychogeriatrics Issue: Volume 30:Number 10(2018) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗